Home > Search: samarium 153

• Search Results

Search Results Get Your Free Credit Report Right Now! Zip Code: Join our discussion forums! Providers join our directory! General Topics A-Z Conditions Treatments Medications Fitness Nutrition Anatomy Travel/Destinations Other Topics From the West From the East

All Topic Areas 1 - 8 of 8 Samarium 153 Lexidronam Quadramet San Marino AcuTect™, Kit Technetium Tc 99m Apcitide Injection Skin, Hair and Nails Skin, Hair, and Nails Snoring Articles 1 - 1 of 1 AcuTect™, Kit Consumer Information AcuTect is a radioactive imaging test used to diagnose acute venous thrombosis (sudden blood clots) in the legs. AcuTect appears to detect acute and not chronic venous thrombosis. If you are experiencing the signs and symptoms of acute venous thrombosis, your doctor will determine whether or not to withhold any anticoagulant drugs (drugs used to thin the blood) that you may be taking. This decision should not be based on a negative AcuTect study alone. If you have a history of drug reactions,... U.S. Food and Drug Administration News 1 - 5 of 13  more >> Fixed Versus Growth Intelligence Mindsets MedicalNewsToday - Thu, 22 Feb 2007 07:00 EST Data From Phase 1 Dose Escalation Study Of QUADRAMET(R) And Bortezomib In Patients With Relapsed Multiple Myeloma MedicalNewsToday - Tue, 12 Dec 2006 08:00 EST Abstract Evaluating QUADRAMET(R) For Multiple Myeloma To Be Presented At 2006 American Society Of Hematology (ASH) Annual Meeting MedicalNewsToday - Tue, 14 Nov 2006 08:00 EST Combination Of High Dose QUADRAMET(R) And Chemotherapy Shows Promise For Treatment Of High-Risk Acute Myeloid Leukemia MedicalNewsToday - Tue, 19 Sep 2006 07:00 EST Cytogen Announces Positive Phase 1 Clinical Trial Results For QUADRAMET(R) Combination Study In High-Risk Prostate Cancer Patients MedicalNewsToday - Wed, 08 Nov 2006 08:00 EST Clinical Trials 1 - 5 of 16  more >> Study of Samarium Sm-153 Lexidronam Combined with Docetaxel for Patients with Prostate Cancer ClinicalTrials.gov Identifier: NCT00121095 - Recruiting Prostatic Neoplasms Samarium 153 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma ClinicalTrials.gov Identifier: NCT00316940 - Active, not recruiting Multiple Myeloma and Plasma Cell Neoplasm Samarium Sm 153 Lexidronam Pentasodium and Autologous Stem Cell Transplant Followed By Radiation Therapy in Treating Patients With Recurrent or Refractory, Metastatic, or Unresectable Osteosarcoma ClinicalTrials.gov Identifier: NCT00245011 - Recruiting Sarcoma Samarium Sm 153 Lexidronam Pentasodium Combined With Zoledronic Acid or Pamidronate in Treating Patients With Relapsed or Refractory Multiple Myeloma and Bone Pain ClinicalTrials.gov Identifier: NCT00482378 - Active, not recruiting Multiple Myeloma and Plasma Cell Neoplasm; Pain Samarium-153 With Neoadjuvant Hormonal and Radiation Therapy for Locally Advanced Prostate Cancer ClinicalTrials.gov Identifier: NCT00328614 - Recruiting Prostate Cancer

GoldBambooTM Your Integrative Health and Wellness Resource November 23, 2009

email this page   |    print this page   |    bookmark this page   |    feedback on this page Page Updated: January 17, 2009

Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.